Intelligence coverage: 65%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ANIK

Anika Therapeutics, Inc.

Healthcare · Surgical & Medical Instruments & Apparatus

$20.68Sep 28, 2026

AI confidence 71% · refreshes every 15s during session

Investment Snapshot

Weak evidence · 1 source

Why it matters

Anika Therapeutics, Inc. shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +16% YoY in Q2 FY2026.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +16% YoY in Q2 FY2026

Pipeline evidence · 0d ago

ANIK's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ANIK.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full ANIK earnings analysis

Reported figures for Anika Therapeutics, Inc. — research only, not investment advice.

Revenue YoY
+15.6%

Latest Intelligence

Updated

What happened recently for Anika Therapeutics, Inc. (ANIK) — events, not interpretation.

Event
Reported Q2 2026 revenue +16% YoY.
Also
Last session September 28, 2026 at $20.68.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Anika Therapeutics, Inc. (ANIK)

Healthcare · Surgical & Medical Instruments & Apparatus

Investment Snapshot above is the primary AlphaOS analysis for Anika Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$276.76M
Revenue:
$32.61M

ANIK earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Anika Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.